Literature DB >> 2405806

A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa.

J E Mitchell1, R L Pyle, E D Eckert, D Hatsukami, C Pomeroy, R Zimmerman.   

Abstract

Previous research on the treatment of outpatients with bulimia nervosa has focused on two treatment strategies: (1) drug therapy, primarily using tricyclic antidepressants, and (2) psychotherapy, often employing behavioral and cognitive behavioral techniques. We report here the short-term treatment outcome of a 12-week comparison trial of bulimic outpatients who were randomly assigned to one of four treatment cells: (1) imipramine hydrochloride treatment, (2) placebo treatment, (3) imipramine treatment combined with intensive group psychotherapy, and (4) placebo treatment combined with intensive group psychotherapy. All three active treatment cells resulted in significant reductions in target-eating behaviors and in a significant improvement in mood relative to placebo treatment. However, the results also suggested that the amount of improvement obtained with the intensive group psychotherapy component was superior to that obtained with antidepressant treatment alone. The addition of antidepressant treatment to the intensive group psychotherapy component did not significantly improve outcome over intensive group psychotherapy combined with placebo treatment in terms of eating behavior, but did result in more improvement in the symptoms of depression and anxiety.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2405806     DOI: 10.1001/archpsyc.1990.01810140049008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  19 in total

Review 1.  Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder.

Authors:  S Krüger; S H Kennedy
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

Review 2.  Antidepressants versus psychological treatments and their combination for bulimia nervosa.

Authors:  J Bacaltchuk; P Hay; R Trefiglio
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 3.  Is anorexia nervosa a neuropsychological disease?

Authors:  C M Braun; M J Chouinard
Journal:  Neuropsychol Rev       Date:  1992-06       Impact factor: 7.444

4.  Cognitive therapy training in u.s. Psychiatry residency programs.

Authors:  E C Ritchie; R White
Journal:  Acad Psychiatry       Date:  1992-06

Review 5.  The changing "weightscape" of bulimia nervosa.

Authors:  Cynthia M Bulik; Marsha D Marcus; Stephanie Zerwas; Michele D Levine; Maria La Via
Journal:  Am J Psychiatry       Date:  2012-10       Impact factor: 18.112

6.  Advances in the Treatment of Anorexia Nervosa and Bulimia Nervosa.

Authors:  S H Kennedy; D S Goldbloom
Journal:  CNS Drugs       Date:  1994-03       Impact factor: 5.749

7.  Cognitive-behavioral therapy versus combined treatment with group psychoeducation and fluoxetine in bulimic outpatients.

Authors:  V Ricca; E Mannucci; B Mezzani; M Di Bernardo; E Barciulli; S Moretti; P L Cabras; C M Rotella
Journal:  Eat Weight Disord       Date:  1997-06       Impact factor: 4.652

Review 8.  Factors that may influence future approaches to the eating disorders.

Authors:  P E Garfinkel; B J Dorian
Journal:  Eat Weight Disord       Date:  1997-03       Impact factor: 4.652

9.  Traditional and new strategies in the primary prevention of eating disorders: a comparative study in Spanish adolescents.

Authors:  Ignacio Jáuregui Lobera; Pilar León Lozano; Patricia Bolaños Ríos; Juan Romero Candau; Gregorio Sánchez Del Villar Y Lebreros; M Teresa Morales Millán; M Teresa Montaña González; Lourdes Andrés Martín; Isabela Justo Villalobos; Nuria Vargas Sánchez
Journal:  Int J Gen Med       Date:  2010-10-05

10.  Stepped care and cognitive-behavioural therapy for bulimia nervosa: randomised trial.

Authors:  James E Mitchell; Stewart Agras; Scott Crow; Katherine Halmi; Christopher G Fairburn; Susan Bryson; Helena Kraemer
Journal:  Br J Psychiatry       Date:  2011-03-17       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.